The ROAMM-EHR Study
Part of paid clinical trials in Gainesville, Florida.
- Sponsor
- University of Florida
- Study ID
- NCT06263322
- Status
- Recruiting
Conditions
- Chronic Limb-Threatening Ischemia
- Peripheral Arterial Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Actionable remotely generated health data — BEHAVIORALRemotely captured, patient generated health data will be used to inform provider care following re-vascular surgery in patients with chronic limb threatening ischemia
- Non-Actionable remotely generated health data — BEHAVIORALRemotely captured, patient generated health data is captured, but will not be used to inform provider care following re-vascular surgery in patients with chronic limb threatening ischemia
Study Details
In recent years, mobile health (mHealth) apps have promised improved monitoring of health conditions to improve clinical outcomes. The objective of this study is to conduct a pilot randomized clinical trial (RCT) to evaluate the impact of using remotely collected patient generated health data (PGHD) from older patients undergoing bypass surgery due to chronic limb threatening ischemia. The hypothesis is that integrating PGHD with an EHR system will help providers manage post-surgical symptoms and thus improve post-operative mobility and quality of life health outcomes.
Key Dates
- Start date
- Nov 16, 2023
- Status verified
- Jun 2025
- Primary completion
- Oct 17, 2026
- Completion
- Oct 17, 2026
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: ROAMM-EHRPatients will wear a smartwatch equipped with a smartwatch app before their surgery and for approximately a month after the surgery. Patients will be asked to wear the watch every day when awake. When wearing the smartwatch, patients will be asked questions about their symptoms following surgery and data will be sent to providers electronically and displayed in their EHR portal. Healthcare Providers will use this information along with patient medical history to decide on the next course of action. The study does not provide specific instructions about how to care for the patient. Those decisions are made by the provider team and their clinical judgement.
- Active Comparator: Active ComparisonThe active comparison patients will wear and respond to questions on the smartwatch. However, the information will not be viewable by their doctor and medical team. All standard of care procedures will remain.
Primary Outcome Measure
6-min walk distance [ Time Frame: Baseline and approximately 30 days post-surgery ]
Central Contacts
- Institute_on_Aging352-273-5919
- HOBI department(352) 627-9467
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Institute of Aging | Gainesville | Florida | 32611 |
Find similar trials in Gainesville, FL
By research site
Related Studies
- Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskPHASE3 · Recruiting · Population Health Research Institute · New Haven, Connecticut
- SELUTION4BTK TrialRecruiting · M.A. Med Alliance S.A. · Chandler, Arizona
- PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaRecruiting · LimFlow, Inc. · La Jolla, California
- The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive DiseaseRecruiting · W.L.Gore & Associates · Little Rock, Arkansas